Advertisement intended for health care professionals

l

Myeloid leukemia of Down syndrome CD61 immunostain

Myeloid leukemia of Down syndrome CD61 immunostain
#00060910
 
Author:  Kristian T. Schafernak
Category:  Myeloid Neoplasms and acute leukemia (WHO 2016) > Acute Myeloid Leukemia > Myeloid proliferations related to Down syndrome > Myeloid Leukemia associated with Down Syndrome
Published Date:  10/28/2016

CD61 (platelet glycoprotein IIIa) immunostain of the bone marrow from a child with Down syndrome who during infancy had transient abnormal myelopoiesis and later developed myeloid (megakaryoblastic) leukemia.  Follow-up is important in such cases because even though the transient abnormal myelopoiesis will usually resolve on its own, myeloid leukemia occurs in 20 to 30% of cases.


Advertisement intended for health care professionals